3/14
04:21 pm
allk
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/14
04:02 pm
allk
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Low
Report
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
2/26
07:20 am
allk
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024 [Yahoo! Finance]
Medium
Report
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024 [Yahoo! Finance]
2/26
07:02 am
allk
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
Medium
Report
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
2/13
03:15 pm
allk
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK
2/12
11:45 pm
allk
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm
Medium
Report
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm
2/12
07:11 am
allk
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition [Yahoo! Finance]
Medium
Report
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition [Yahoo! Finance]
2/12
07:02 am
allk
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
Medium
Report
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
3/14/2024
04:02 pm
allk
allakos inc.
MISS
Report
0.4%
allakos inc.
11/13/2023
04:02 pm
allk
allakos inc.
MISS
Report
1.7%
allakos inc.
8/9/2023
04:02 pm
allk
allakos inc.
BEAT
Report
-8.0%
allakos inc.
8/9/2023
04:02 pm
allk
allakos inc.
BEAT
Report
-8.0%
allakos inc.
3/14
04:21 pm
allk
Form 10-K Allakos Inc. For: Dec 31
Low
Report
Form 10-K Allakos Inc. For: Dec 31
3/14
04:16 pm
allk
Form 8-K Allakos Inc. For: Mar 14
Low
Report
Form 8-K Allakos Inc. For: Mar 14
3/7
05:00 pm
allk
Form 4 Allakos Inc. For: Mar 06 Filed by: Radford Harlan Baird
Medium
Report
Form 4 Allakos Inc. For: Mar 06 Filed by: Radford Harlan Baird
3/6
06:05 pm
allk
Form 4 Allakos Inc. For: Mar 05 Filed by: Tomasi Adam
Low
Report
Form 4 Allakos Inc. For: Mar 05 Filed by: Tomasi Adam
3/6
06:05 pm
allk
Form 4 Allakos Inc. For: Mar 04 Filed by: Alexander Robert
Low
Report
Form 4 Allakos Inc. For: Mar 04 Filed by: Alexander Robert
3/5
04:23 pm
allk
Form 144 Allakos Inc. Filed by: Tomasi Adam
Medium
Report
Form 144 Allakos Inc. Filed by: Tomasi Adam
3/4
05:53 pm
allk
Form 144 Allakos Inc. Filed by: Alexander Robert
Medium
Report
Form 144 Allakos Inc. Filed by: Alexander Robert
2/26
07:05 am
allk
Form 8-K Allakos Inc. For: Feb 26
Medium
Report
Form 8-K Allakos Inc. For: Feb 26
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
8/5
Form 8-K Allakos Inc. For: Aug 01
110.5%
12/3
Form 4 Allakos Inc. For: Nov 29 Filed by: Alexander Robert
43.6%
8/5
Form 8-K Allakos Inc. For: Aug 05
26.9%
4/9
Allakos Inc (NASDAQ: ALLK) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating.
19.5%
3/18
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Losses to Contact Its Attorneys: Application Deadline Approaching
11.3%
8/6
Form 3 Allakos Inc. For: Aug 01 Filed by: Redmond Leo
9.4%
3/17
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. – ALLK
8.1%
2/28
Allakos Inc (NASDAQ: ALLK) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
6.3%
3/9
ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc. – ALLK
6.1%
4/1
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates AAN, ALGN, ALLK, CCI Investors, Encourages Investors with Losses to Contact Firm
5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register